Celladon Hopes To Bring Gene-Therapy Solution To Heart Failure Patients
This article was originally published in The Pink Sheet Daily
Executive Summary
Improving heart contractility by increasing levels of the SERCA2a gene is a new approach to a familiar problem in treating heart failure.